Fatal disseminated toxoplasmosis in a feline immunodeficiency virus‐positive cat receiving oclacitinib for feline atopic skin syndrome

Moore, A., Burrows, A.K.ORCID: 0000-0001-9293-1352, Malik, R., Ghubash, R.M., Last, R.D. and Remaj, B. (2022) Fatal disseminated toxoplasmosis in a feline immunodeficiency virus‐positive cat receiving oclacitinib for feline atopic skin syndrome. Veterinary Dermatology . Early View.

Abstract

Toxoplasma gondii is a ubiquitous protozoan, for which felids are the definitive host. Immunocompromised individuals are susceptible to recrudescent toxoplasmosis. This case describes a 6-year-old, feline immunodeficiency virus-positive domestic short hair cat with feline atopic skin syndrome that developed fatal toxoplasmosis after treatment with oclacitinib for five months.

Item Type:	Journal Article
Murdoch Affiliation(s):	Veterinary Medicine
Publisher:	John Wiley & Sons Ltd on behalf of ESVD and ACVD.
Copyright:	© 2022 The Authors.
URI:	http://researchrepository.murdoch.edu.au/id/eprint/65062

Item Control Page

Downloads